Matthew Sorrentino
Overview
Explore the profile of Matthew Sorrentino including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
11
Citations
145
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Cifu A, Sorrentino M, Siegler M, Krapec J
Acad Med
. 2023 Feb;
98(6S):S1-S2.
PMID: 36812045
No abstract available.
2.
Sorrentino M, Krapec J, Cifu A, Pace-Moody A, Siegler M
Acad Med
. 2023 Feb;
98(6S):S3-S5.
PMID: 36811976
The Bucksbaum Institute for Clinical Excellence at the University of Chicago was established in 2011 with the mission to improve patient care, strengthen the doctor-patient relationship, enhance communication and decision...
3.
Bakris G, Sorrentino M
Eur Heart J
. 2019 Apr;
39(33):3008-3009.
PMID: 30990868
No abstract available.
4.
Polster S, Stadnik A, Akers A, Cao Y, Christoforidis G, Fam M, et al.
Neurosurgery
. 2018 Nov;
85(6):843-853.
PMID: 30476251
Background: More than a million Americans harbor a cerebral cavernous angioma (CA), and those who suffer a prior symptomatic hemorrhage have an exceptionally high rebleeding risk. Preclinical studies show that...
5.
Brandt E, Benes L, Lee L, Dayspring T, Sorrentino M, Davidson M
J Cardiovasc Pharmacol Ther
. 2018 Jun;
24(1):54-61.
PMID: 29940784
Background: Proprotein convertase subtilisin/kexin type 9 (PCSK9) is expressed in multiple tissues, including the small intestine. The effect of PCSK9 inhibition on cholesterol absorption is not known. Objectives: Measure serum...
6.
Bakris G, Sorrentino M
N Engl J Med
. 2018 Jan;
378(6):497-499.
PMID: 29341841
No abstract available.
7.
Kaufman A, Spitz J, Jacobs M, Sorrentino M, Yuen S, Danahey K, et al.
Mayo Clin Proc
. 2015 Jun;
90(6):716-29.
PMID: 26046407
Objective: To comprehensively assess the pharmacogenomic evidence of routinely used drugs for clinical utility. Methods: Between January 2, 2011, and May 31, 2013, we assessed 71 drugs by identifying all...
8.
Deano R, Sorrentino M
Curr Atheroscler Rep
. 2011 Nov;
14(1):70-7.
PMID: 22037772
Thiazide diuretics and beta-blockers are first-line therapies for hypertension unless there are compelling indications for other drug classes. Diuretics and beta-blockers, however, may worsen dyslipidemia and glucose tolerance whereas antihypertensive...
9.
DeVore A, Sorrentino M, Arnsdorf M, Ward R, Bakris G, Blankstein R
J Clin Hypertens (Greenwich)
. 2010 Aug;
12(8):570-7.
PMID: 20695933
Factors influencing hypertension (HTN) control in the United States are not well understood. The authors utilized a newly designed survey instrument to interview patients presenting to a diverse, general cardiology...
10.
Lin E, Boire A, Hemmige V, Husain A, Sorrentino M, Nathan S, et al.
J Med Case Rep
. 2010 Aug;
4:246.
PMID: 20684780
Introduction: Chronic lymphocytic leukemia is an indolent disease that often presents with complaints of lymphadenopathy or is detected as an incidental laboratory finding. It is rarely considered in the differential...